Skip to content
OpenCapital
Get started

Citius Oncology, Inc. CTOR Investment Income Interest

Investment Income Interest at other companies

DJT
Trump Media & Technology GroupDJT
$7.23M-9.6%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$959.76K+118%
HTF
Heartflow, Inc. Common StockHTFL
$2.46M+354%
Solidion Technology, Inc. logo
Solidion Technology, Inc.STI
$191-98.8%
Wrap Technologies logo
Wrap TechnologiesWRAP
$1K-50.0%
Avanos Medical logo
Avanos MedicalAVNS
$200K-86.7%

Other financials

Income statement

See full
Revenue$1.7M—
Gross profit$1.3M—
Operating income-$28.6M-283%
Net income-$26.6M-244%
EPS (diluted)-$0.27-145%

Balance sheet

See full
Cash & equivalents$2.6M+2,350,466%
Total equity$35.3M-1.0%
Total assets$100.7M+10.1%

Cash flow

See full
Operating cash flow-$3.8M-179%

Valuation

See full
Market cap$60.45M-74.7%

Returns & leverage

See full
Return on equity-119.9%+46.7pp
Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s investment income interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Citius Oncology, Inc.'s investment income interest?
Citius Oncology, Inc. (CTOR) reported investment income interest of $43.72K in Q1 2026.
How has Citius Oncology, Inc.'s investment income interest changed year-over-year?
Citius Oncology, Inc.'s investment income interest increased by 380.8% year-over-year, from $9.09K to $43.72K.
What does investment income interest mean?
Reflects the revenue generated from cash balances, marketable securities, or other financial instruments held by the company. This metric provides insight into the company's treasury management and the yield earned on its liquid assets.